Dr. Reddy's Says Amarin Delaying Heart Drug Competition
Dr. Reddy's Laboratories Inc. has said that Amarin Pharma is trying to hinder generic competition of its heart drug Vascepa by cutting deals that keep generic makers from getting their hands...To view the full article, register now.
Already a subscriber? Click here to view full article